Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyell Immunopharma (LYEL) Free Cash Flow: 2019-2024

Historic Free Cash Flow for Lyell Immunopharma (LYEL) over the last 6 years, with Dec 2024 value amounting to -$162.9 million.

  • Lyell Immunopharma's Free Cash Flow rose 18.41% to -$28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$165.5 million, marking a year-over-year decrease of 5.95%. This contributed to the annual value of -$162.9 million for FY2024, which is 2.12% up from last year.
  • As of FY2024, Lyell Immunopharma's Free Cash Flow stood at -$162.9 million, which was up 2.12% from -$166.4 million recorded in FY2023.
  • Lyell Immunopharma's Free Cash Flow's 5-year high stood at -$162.9 million during FY2024, with a 5-year trough of -$212.4 million in FY2020.
  • For the 3-year period, Lyell Immunopharma's Free Cash Flow averaged around -$174.4 million, with its median value being -$166.4 million (2023).
  • Per our database at Business Quant, Lyell Immunopharma's Free Cash Flow plummeted by 1,006.45% in 2020 and then grew by 14.16% in 2023.
  • Over the past 5 years, Lyell Immunopharma's Free Cash Flow (Yearly) stood at -$212.4 million in 2020, then increased by 9.70% to -$191.8 million in 2021, then decreased by 1.08% to -$193.8 million in 2022, then grew by 14.16% to -$166.4 million in 2023, then grew by 2.12% to -$162.9 million in 2024.